Catalyst Biosciences is a biotechnology business based in the US. Catalyst Biosciences shares (CBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Catalyst Biosciences employs 7 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Catalyst Biosciences stock
How to buy Catalyst Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CBIO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Catalyst Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Catalyst Biosciences stock price (NASDAQ: CBIO)
Use our graph to track the performance of CBIO stocks over time.Catalyst Biosciences shares at a glance
Latest market close | $26.30 |
---|---|
52-week range | $4.80 - $30.40 |
50-day moving average | $0.64 |
200-day moving average | $0.37 |
Wall St. target price | $16.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-20.70 |
Is it a good time to buy Catalyst Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Catalyst Biosciences price performance over time
Historical closes compared with the close of $26.3 from 2023-11-29
1 week (2024-08-27) | N/A |
---|---|
1 month (2024-08-03) | N/A |
3 months (2024-06-03) | N/A |
6 months (2024-03-03) | N/A |
1 year (2023-09-07) | 4,893.35% |
---|---|
2 years (2022-09-07) | 1,255.67% |
3 years (2021-09-07) | 505.99% |
5 years (2019-09-06) | 325.57% |
Is Catalyst Biosciences stock undervalued or overvalued?
Valuing Catalyst Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Catalyst Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Catalyst Biosciences's PEG ratio
Catalyst Biosciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.02. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Catalyst Biosciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Catalyst Biosciences financials
Gross profit TTM | $-64,906,000 |
---|---|
Return on assets TTM | -41.29% |
Return on equity TTM | -269.01% |
Profit margin | 0% |
Book value | $-11.77 |
Market Capitalization | $19.4 million |
TTM: trailing 12 months
Catalyst Biosciences share dividends
We're not expecting Catalyst Biosciences to pay a dividend over the next 12 months.
Have Catalyst Biosciences's shares ever split?
Catalyst Biosciences's shares were split on a 1:15 basis on 12 February 2017. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Catalyst Biosciences shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Catalyst Biosciences shares which in turn could have impacted Catalyst Biosciences's share price.
Catalyst Biosciences share price volatility
Over the last 12 months, Catalyst Biosciences's shares have ranged in value from as little as $4.8 up to $30.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Catalyst Biosciences's is 1.29. This would suggest that Catalyst Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Catalyst Biosciences overview
Catalyst Biosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California. .
Frequently asked questions
nullWhat percentage of Catalyst Biosciences is owned by insiders or institutions?
Currently 27.734% of Catalyst Biosciences shares are held by insiders and 8.752% by institutions. How many people work for Catalyst Biosciences?
Latest data suggests 7 work at Catalyst Biosciences. When does the fiscal year end for Catalyst Biosciences?
Catalyst Biosciences's fiscal year ends in December. Where is Catalyst Biosciences based?
Catalyst Biosciences's address is: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 What is Catalyst Biosciences's ISIN number?
Catalyst Biosciences's international securities identification number is: US14888D2080 What is Catalyst Biosciences's CUSIP number?
Catalyst Biosciences's Committee on Uniform Securities Identification Procedures number is: 14888D109
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question